SEC annual filings · Instruments and related products
Which companies in instruments and related products have the most revenue in the SEC data we read?
In 2025, 73 companies in instruments and related products that have had revenue of one billion dollars or more are ranked; Thermo Fisher Scientific Inc. reported the most, $44.6 billion. The newest annual report in the data is for the fiscal year ended .
Right now
Thermo Fisher Scientific Inc. reported the most revenue in 2025, $44.6 billion.
73 companies in instruments and related products are ranked for 2025.
Share of revenueOurs
Together they reported $562.1 billion of revenue, 2.2% of the revenue of all $25.2 trillion reported by the ranked companies.
As filed
Facts as filed with the SEC, and our arithmetic on them. Not investment advice.
Total assets are the figure the SEC data holds for the fiscal year end; a dash can mean the data holds a balance of another date.
Understanding the ranking
Where it stands today
Thermo Fisher Scientific Inc. reported $44.6 billion, the most in 2025.
How is the ranking made?
The ranking lists companies by the revenue they filed with the SEC for their fiscal year in 2025, the largest first.
Read more
A company is in the ranking when its latest annual report shows revenue of one billion dollars or more, and stays in it afterwards. A company that has stopped filing keeps its page and is not ranked.
The numbers behind the chart
Which companies in instruments and related products reported the most revenue?73 companies
| Company | Rank | Symbol | Revenue | Profit or loss | Total assets |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. | 1 | TMO | $44.6B | $6.72B | $110B |
| Northrop Grumman Corp | 2 | NOC | $42.0B | $4.18B | $51.4B |
| Medtronic plc | 3 | MDT | $36.4B | – | – |
| Medline Inc. | 4 | MDLN | $28.4B | – | $38.5B |
| Stryker Corp | 5 | SYK | $25.1B | $3.25B | $47.8B |
| 3M Co | 6 | MMM | $24.9B | $3.25B | $37.7B |
| Danaher Corp | 7 | DHR | $24.6B | $3.61B | $83.5B |
| Becton Dickinson & Co | 8 | BDX | $21.8B | $1.68B | – |
| Trane Technologies plc | 9 | TT | $21.3B | $2.92B | $21.4B |
| GE HealthCare Technologies Inc. | 10 | GEHC | $20.6B | $2.08B | $36.9B |
| Boston Scientific Corp | 11 | BSX | $20.1B | – | $43.7B |
| KLA Corp | 12 | KLAC | $12.2B | $4.06B | – |
| Baxter International Inc | 13 | BAX | $11.2B | −$957M | $20.1B |
| Intuitive Surgical Inc | 14 | ISRG | $10.1B | $2.86B | $20.5B |
| Rockwell Automation, Inc | 15 | ROK | $8.34B | $869M | – |
| Solventum Corp | 16 | SOLV | $8.32B | $1.56B | $14.3B |
| Zimmer Biomet Holdings, Inc. | 17 | ZBH | $8.23B | $705M | $23.1B |
| Roper Technologies Inc | 18 | ROP | $7.90B | $1.54B | $34.6B |
| Ametek Inc | 19 | AME | $7.40B | $1.48B | $16.1B |
| Garmin Ltd | 20 | GRMN | $7.25B | $1.66B | $11.0B |
| Agilent Technologies, Inc. | 21 | A | $6.95B | $1.30B | – |
| Avantor, Inc. | 22 | AVTR | $6.55B | −$530M | $11.8B |
| Teledyne Technologies Inc | 23 | TDY | $6.12B | $895M | $15.3B |
| Edwards Lifesciences Corp | 24 | EW | $6.07B | $1.07B | $13.7B |
| STERIS plc | 25 | STE | $5.94B | $782M | – |
Show 48 more rows
| Company | Rank | Symbol | Revenue | Profit or loss | Total assets |
|---|---|---|---|---|---|
| Coherent Corp. | 26 | COHR | $5.81B | $30.0M | – |
| Veralto Corp | 27 | VLTO | $5.50B | $940M | $7.69B |
| Keysight Technologies, Inc. | 28 | KEYS | $5.38B | $850M | – |
| ResMed Inc | 29 | RMD | $5.15B | $1.40B | – |
| Bausch & Lomb Corp | 30 | BLCO | $5.10B | −$360M | $14.0B |
| DexCom Inc | 31 | DXCM | $4.66B | $836M | $6.34B |
| Illumina, Inc. | 32 | ILMN | $4.34B | $850M | $6.64B |
| Fortive Corp | 33 | FTV | $4.16B | $533M | $11.7B |
| Hologic Inc | 34 | – | $4.10B | $566M | – |
| Cooper Companies, Inc. | 35 | COO | $4.09B | $375M | – |
| Align Technology Inc | 36 | ALGN | $4.03B | $410M | $6.23B |
| Mettler-Toledo International Inc | 37 | MTD | $4.03B | $869M | $3.71B |
| MKS Inc | 38 | MKSI | $3.93B | $295M | $8.80B |
| Sensata Technologies Holding plc | 39 | ST | $3.70B | $31.3M | $6.75B |
| Dentsply Sirona Inc. | 40 | XRAY | $3.68B | −$598M | $5.43B |
| Leonardo DRS, Inc. | 41 | DRS | $3.65B | $278M | $4.49B |
| Trimble Inc. | 42 | TRMB | $3.59B | $424M | $9.31B |
| Bruker Corp | 43 | BRKR | $3.44B | −$8.30M | $6.24B |
| Teradyne, Inc | 44 | TER | $3.19B | $554M | $4.18B |
| Waters Corp | 45 | WAT | $3.17B | $643M | $5.08B |
| MiniMed Group, Inc. | 46 | MMED | $3.10B | −$333M | – |
| Vontier Corp | 47 | VNT | $3.08B | $406M | $4.37B |
| West Pharmaceutical Services Inc | 48 | WST | $3.07B | $494M | $4.27B |
| Globus Medical Inc | 49 | GMED | $2.94B | $538M | $5.30B |
| Revvity, Inc. | 50 | RVTY | $2.86B | $241M | $12.2B |
| Envista Holdings Corp | 51 | NVST | $2.72B | $47.0M | $5.68B |
| Insulet Corp | 52 | PODD | $2.71B | $247M | $3.19B |
| Bio-Rad Laboratories, Inc. | 53 | BIO | $2.58B | $760M | $10.6B |
| Itron, Inc. | 54 | ITRI | $2.37B | $301M | $3.72B |
| Enovis Corp | 55 | ENOV | $2.25B | −$1.18B | $3.83B |
| ICU Medical Inc | 56 | ICUI | $2.23B | – | $4.05B |
| Ralliant Corp | 57 | RAL | $2.07B | −$1.22B | $3.82B |
| Teleflex Inc | 58 | TFX | $1.99B | −$906M | $6.95B |
| National Vision Holdings, Inc. | 59 | EYE | $1.99B | $29.6M | $1.98B |
| MSA Safety Inc | 60 | MSA | $1.87B | $279M | $2.55B |
| Integer Holdings Corp | 61 | ITGR | $1.85B | $103M | $3.41B |
| Integra Lifesciences Holdings Corp | 62 | IART | $1.64B | −$517M | $3.60B |
| Masimo Corp | 63 | – | $1.53B | −$152M | $1.70B |
| Merit Medical Systems Inc | 64 | MMSI | $1.52B | $128M | $2.69B |
| Penumbra Inc | 65 | PEN | $1.40B | $178M | $1.83B |
| LivaNova plc | 66 | LIVN | $1.39B | −$243M | $2.61B |
| CONMED Corp | 67 | CNMD | $1.37B | $47.1M | $2.33B |
| Haemonetics Corp | 68 | HAE | $1.33B | – | – |
| Embecta Corp. | 69 | EMBC | $1.08B | $95.4M | – |
| Eastman Kodak Co | 70 | KODK | $1.07B | −$128M | $1.62B |
| Tandem Diabetes Care Inc | 71 | TNDM | $1.01B | −$205M | $881M |
| Onto Innovation Inc. | 72 | ONTO | $1.01B | – | $2.37B |
| Fossil Group, Inc. | 73 | FOSL | $1.00B | – | $689M |
The table scrolls sideways; the first column stays in place.
What does the ranking leave out, and where is it from?Limits and source
What this number cannot tell you
- Only companies with a revenue figure for the ranking year that passes our checks are ranked, the largest first; equal figures share a rank.
- A company's figures are its own. A company that files together with a parent or a subsidiary is ranked on its own figure, so the same business can appear twice, and a sum of revenue counts it twice.
- Total assets are shown only when the SEC data dates them within ten days of the fiscal year end, and profit only when its period ends within sixty days of it.
- A dash is a gap. Either the company did not report that figure for that year, the figure failed one of our checks and is not shown, or the SEC data holds it for another date or period than the year asks for. The dash says which when it is pointed at.
Observed .
Page updated